| 5V19: reference: Structure-based drug design of novel ASK1 inhibitors using an integrated lead optimization strategy., Gibson TS, Johnson B, Fanjul A, Halkowycz P, Dougan DR, Cole D, Swann S, Bioorg Med Chem Lett. 2017 Mar 2. pii: S0960-894X(17)30222-6. doi:, 10.1016/j.bmcl.2017.02.079. PMID: 28291695 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).